Sam – Page 597 – biolegacy

The FDA is continuing its crackdown on Chinese drugmakers, adding three more companies this week to its import alert lists over faulty GMP practices and a refusal for inspection. Source:…

Senator Criticizes FDA for Approach to Oxilofrine in Supplements

Post author:Sam
Post published:April 8, 2016
Post category:Drug Industry Daily

Sen. Claire McCaskill (D-Mo.) is taking the FDA to task for its delayed reaction in targeting companies marketing supplements containing oxilofrine, a stimulant banned by the World Anti-Doping Agency for…

BIO-QUANT announces the expansion of its research animal diagnostic services to cover all nine species

Post author:Sam
Post published:April 8, 2016
Post category:News

BIO-QUANT ANNOUNCES THE EXPANSION OF ITS RESEARCH ANIMAL DIAGNOSTIC SERVICES TO COVER ALL NINE SPECIES. SAN DIEGO, CA, September, 2008 --Bio-Quant Inc ("Bio-Quant") the largest biotech Contract Research Organization (CRO)…

BIO-QUANT credited in TRIUS POSTER

Post author:Sam
Post published:April 8, 2016
Post category:News

BIO-QUANT credited in TRIUS POSTER.

BIO-QUANT credited in XOMA POSTER

Post author:Sam
Post published:April 8, 2016
Post category:News

BIO-QUANT credited in XOMA POSTER.

HMGB1 Studies in wound healing. SOURCE: Bio-Quant, Inc. HMGB1 Studies in wound healing.

Post author:Sam
Post published:April 8, 2016
Post category:News

Bio3 Research S.r.l. (Milano – Italy), is pleased to announce the positive preclinical studies outcome (conducted by the CRO Bio-Quant Inc. La Jolla/CA) obtained with HMGB1 in wound healing in…